Sustained preconditioning induced by cardiac transgenesis with the tetracycline transactivator

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 3, 2006, Pages

  Turnbull, Lynne ^a,c   Zhou, Hui Zhong ^a,c   Swigart, Philip M ^a,c   Turcato, Sally ^a,c   Karliner, Joel S ^a,b,c   Conklin, Bruce R ^a,b   Simpson, Paul C ^a,b,c   Baker, Anthony J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

myosin heavy chain; Cardioprotection; Contraction; Langendorff; Mouse; Tetracycline regulated gene expression system

Indexed keywords

5 HYDROXYDECANOIC ACID; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE RECEPTOR; CHELERYTHRINE; LACTATE DEHYDROGENASE; MYOSIN HEAVY CHAIN ALPHA; POTASSIUM CHANNEL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TETRACYCLINE DERIVATIVE; TRANSACTIVATOR PROTEIN; RECOMBINANT PROTEIN; TETRACYCLINE; VENTRICULAR MYOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; DRUG MECHANISM; ENZYME RELEASE; FEMALE; GENE EXPRESSION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENICS; ANIMAL; GENE THERAPY; GENETICS; HEART LEFT VENTRICLE FUNCTION; ISCHEMIC PRECONDITIONING; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; REPERFUSION INJURY; TRANSGENIC MOUSE; TREATMENT OUTCOME;

ANIMALS; FEMALE; GENE THERAPY; ISCHEMIC PRECONDITIONING; MALE; MICE; MICE, TRANSGENIC; RECOMBINANT PROTEINS; REPERFUSION INJURY; TETRACYCLINE; TRANS-ACTIVATORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR MYOSINS;

EID: 33645741666     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00732.2005     Document Type: Article

References (33)

1. Akagi K, Kanai M, Saya H, Kozu T, and Berns A. A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain. Nucleic Acids Res 29: E23, 2001.
2. i-coupled receptor in transgenic model of dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 280: H1653-H1659, 2001.
3. Baron U, Gossen M, and Bujard H. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 25: 2723-2729, 1997.
4. Beggah AT, Escoubet B, Puttini S, Cailmail S, Delage V, Ouvrard-Pascaud A, Bocchi B, Peuchmaur M, Delcayre C, Farman N, and Jaisser F. Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes. Proc Natl Acad Sci USA 99: 7160-7165, 2002.
5. Bowman JC, Steinberg SF, Jiang T, Geenen DL, Fishman GI, and Buttrick PM. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest 100: 2189-2195, 1997.
6. Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, and Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101: 1833-1839, 2000.
7. Dalal H, Evans PH, and Campbell JL. Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction. BMJ 328: 693-697, 2004.
8. Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, Carmeliet P, Goelman G, and Keshet E. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 21: 1939-1947, 2002.
9. Fishman GI. Timing is everything in life: conditional transgene expression in the cardiovascular system. Circ Res 82: 837-844, 1998.
10. Fryer RM, Auchampach JA, and Gross GJ. Therapeutic receptor targets of ischemic preconditioning. Cardiovasc Res 55: 520-525, 2002.
11. Furth PA, St. Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, and Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91: 9302-9306, 1994.
12. Gossen M and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551, 1992.
13. Hwang DY, Chae KR, Shin DH, Hwang JH, Lim CH, Kim YJ, Kim BJ, Goo JS, Shin YY, Jang IS, Cho JS, and Kim YK. Xenobiotic response in humanized double transgenic mice expressing tetracycline-controlled transactivator and human CYP1B1. Arch Biochem Biophys 395: 32-40, 2001.
14. Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, Messing RO, Goetzl EJ, Karliner JS, and Gray MO. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCε knockout mouse hearts. Am J Physiol Heart Circ Physiol 282: H1970-H1977, 2002.
15. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, and Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93: 10933-10938, 1996.
16. Laclau MN, Boudina S, Thambo JB, Tariosse L, Gouverneur G, Bonoron-Adele S, Saks VA, Garlid KD, and Dos Santos P. Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol 33: 947-956, 2001.
17. Matherne GP, Linden J, Byford AM, Gauthier NS, and Headrick JP. Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci USA 94: 6541-6546, 1997.
18. McCloskey DT, Turnbull L, Swigart P, O'Connell TD, Simpson PC, and Baker AJ. Abnormal myocardial contraction in alpha(1A)- and alpha(1B)-adrenoceptor double-knockout mice. J Mol Cell Cardiol 35: 1207-1216, 2003.
19. McCloskey DT, Turnbull L, Swigart PM, Zambon AC, Turcato S, Joho S, Grossman W, Conklin BR, Simpson PC, and Baker AJ. Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression. Physiol Genomics 22: 118-126, 2005.
20. Miyamae M, Diamond I, Weiner MW, Camacho SA, and Figueredo VM. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci USA 94: 3235-3239, 1997.
21. Miyamae M, Rodriguez MM, Camacho SA, Diamond I, Mochly-Rosen D, and Figueredo VM. Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci USA 95: 8262-8267, 1998.
22. Murry C, Jennings R, and Reimer K. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
23. Peart J, Willems L, and Headrick JP. Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine. Am J Physiol Heart Circ Physiol 284: H519-H527, 2003.
24. i-coupled receptor in transgenic mice. Nat Biotechnol 17: 165-169, 1999.
25. i-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci USA 97: 4826-4831, 2000.
26. Sanbe A, Gulick J, Hanks MC, Liang Q, Osinska H, and Robbins J. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res 92: 609-616, 2003.
27. Steenbergen C, Murphy E, Watts JA, and London RE. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 66: 135-146, 1990.
28. Suzuki J, Shen WJ, Nelson BD, Patel S, Veerkamp JH, Selwood SP, Murphy GM Jr, Reaven E, and Kraemer FB. Absence of cardiac lipid accumulation in transgenic mice with heart-specific HSL overexpression. Am J Physiol Endocrinol Metab 281: E857-E866, 2001.
29. 1D-AR. Am J Physiol Heart Circ Physiol 284: H1104-H1109, 2003.
30. Yang LL, Gros R, Kabir MG, Sadi A, Gotlieb AI, Husain M, and Stewart DJ. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation 109: 255-261, 2004.
31. Yellon DM and Dana A. The preconditioning phenomenon: a tool for the scientist or a clinical reality? Circ Res 87: 543-550, 2000.
32. Yu Z, Redfern CS, and Fishman GI. Conditional transgene expression in the heart. Circ Res 79: 691-697, 1996.
33. Zhu P, Zhou HZ, and Gray MO. Chronic ethanol-induced myocardial protection requires activation of mitochondrial K(ATP) channels. J Mol Cell Cardiol 32: 2091-2095, 2000.